TWEAK progress in dermatology: A review
Tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a member of the TNF superfamily (TNFSF). It acts through its receptor fibroblast growth factor-inducible 14 (Fn14). Studies have indicated that TWEAK/Fn14 pathway activation controls multiple cellular responses, including prolife...
Main Authors: | Pramisha Kharel, Chen Jia, Kamal Raj Dhital, Pukar Chapagain, Sabita Aryal |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Indian Journal of Dermatology |
Subjects: | |
Online Access: | http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=4;spage=425;epage=429;aulast=Kharel |
Similar Items
-
Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro
by: Antonio Altuna-Coy, et al.
Published: (2021-09-01) -
Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury
by: Melania Guerrero-Hue, et al.
Published: (2023-12-01) -
Sarcopenia is associated with hypomethylation of TWEAK and increased plasma levels of TWEAK and its downstream inflammatory factor TNF-α in older adults: A case-control study
by: Saiyare Xuekelati, et al.
Published: (2024-04-01) -
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges
by: Nerea Méndez-Barbero, et al.
Published: (2020-02-01) -
Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes
by: Leticia Cuarental, et al.
Published: (2020-07-01)